@notanotherrokabag I know you're trying to help. The thing is, you (and I) don't know exactly what conversations have been had between posters using long cycle HRT and their drs. eg Have they been advised to report odd bleeding asap?
The new report from the BMS is certainly very forceful. my own view is that it's perhaps there to contain the use of off-label very high estrogen doses that some women have been given.
Looking at it more positively, the report does stress that endo cancer on HRT is rare and less than women not using HRT who report odd bleeding (post menopause.)
One encouraging fact they now include is that they allow an endo thickness of 7mm on women using sequential HRT which is a change from 'under 5mm'. This ought to prevent a lot of unnecessary biopsies.
Before, women were being put through (often) unnecessary investigations, yet it's been known for years (my personal experience with specialists) that a higher limit was reasonable when on a sequential regimen.
I do agree that an annual scan should be factored into 3-monthly regimens but sadly the NHS doesn't have the money or time for this. (Although women can ask to be referred privately if they can afford it.)
The main point is that hyperplasia almost always shows with bleeding, so a scan would be done and treatment carried out accordingly. The stats are also reassuring. Last time I looked at this, after a year on estrogen only, (which isn't done now but was in the past when HRT first came in) 20% of women would have hyperplasia but only a small percentage (I think it was around 1%) would have endo cancer. The stats on the link from the BMS give figures as percentages but not absolute numbers.
You're right to draw attention to it and yes, women should know there is a small risk and be ready to ask for a scan if they have symptoms.